.png?width=2400&height=263&name=Emergent-BioServices_CMYK_Logo-Tagline-Lockup%20(2).png "Emergent BioSolutions CDMO"){kind=logo}
05.12.2021
Rockville, MD Expansion Progress
Our drug product manufacturing facility in Rockville, Maryland is undergoing an expansion that will soon house a...
02.13.2021
Emergent Enters Into a New CDMO Agreement with Providence Therapeutics to Provide Fill/Finish Drug Product Manufacturing
Emergent has entered into a new CDMO agreement with Providence Therapeutics to provide fill/finish drug product manufacturing...
01.25.2021
Humanigen and Emergent BioSolutions Announce Contract Development and Manufacturing Agreement for Phase 3 COVID-19 Therapeutic Candidate Lenzilumab™
GAITHERSBURG, MD. and BURLINGAME, CA. – Jan. 25, 2021—Emergent BioSolutions Inc.(NYSE:EBS) (Emergent) andHumanigen, Inc....
10.01.2020
Bloomberg: The Way Ahead
Emergent BioSolutions, a Wells Fargo Corporate & Investment Banking customer since 2011, helps governments respond to health...
09.01.2020
All Hands on Deck for Fill/Finish of Vaccines and Therapeutics
“Emergent has a long, successful history of working with the US government to develop, manufacture, and deliver safe and...
07.07.2020
EMERGENT IN THE NEWS: COVID-19 General Coverage
Read the latest news coverage of Emergent's insights and involvement in the fight against COVID-19. Last Updated: Thursday,...